Mid-season influenza vaccine effectiveness estimates among DOD populations: a composite of data presented at VRBPAC-the Vaccines and Related Biological Products Advisory Committee-2024 meeting on influenza vaccine strain selection for the 2024-2025 influenza season

MSMR. 2024 Mar 20;31(3):20-23.
No abstract available

Keywords: Department of Defense; effectiveness; flu; influenza; strain; vaccine.

MeSH terms

  • Advisory Committees
  • Biological Products*
  • Humans
  • Infant
  • Influenza A Virus, H3N2 Subtype
  • Influenza Vaccines* / therapeutic use
  • Influenza, Human* / epidemiology
  • Influenza, Human* / prevention & control
  • Military Personnel*
  • Seasons
  • United States / epidemiology
  • Vaccination
  • Vaccine Efficacy

Substances

  • Influenza Vaccines
  • Biological Products